Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Oscar F Beas-GuzmánDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0002-4239-4971
Ariana Cabrera-LiconaState Cancerology Institute of Colima, Health Services of the Mexican Social Security Institute for Welfare (IMSS-BIENESTAR), Colima 28085, Mexico.ORCID 0000-0002-2549-4823
Gustavo A Hernández-FuentesDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0003-4685-3095
Silvia G Ceballos-MagañaFaculty of Sciences, University of Colima, Colima 28045, Mexico.
José Guzmán-EsquivelClinical Epidemiology Research Unit, Mexican Institute of Social Security, Villa de Alvarez, Colima 28984, Mexico.ORCID 0000-0002-6727-0051
Luis De-León-ZaragozaState Cancerology Institute of Colima, Health Services of the Mexican Social Security Institute for Welfare (IMSS-BIENESTAR), Colima 28085, Mexico.
Mario Ramírez-FloresDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0003-3375-715X
Janet Diaz-MartinezResearch Center in Minority Institutions, Florida International University (FIU-RCMI), Miami, FL 33199, USA.ORCID 0000-0003-3295-4768
Idalia Garza-VelozMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0002-6307-1696
Margarita L Martínez-FierroMolecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico.ORCID 0000-0003-1478-9068
Iram P Rodríguez-SanchezMolecular and Structural Physiology Laboratory, School of Biological Sciences, Autonomous University of Nuevo Leon, San Nicolas de los Garza 66455, Mexico.ORCID 0000-0002-5988-4168
Gabriel Ceja-EspírituDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Carmen Meza-RoblesState Cancerology Institute of Colima, Health Services of the Mexican Social Security Institute for Welfare (IMSS-BIENESTAR), Colima 28085, Mexico.ORCID 0000-0002-5075-1166
Víctor H Cervantes-KardaschDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.
Iván Delgado-EncisoDepartment of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.ORCID 0000-0001-9848-862X
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
Averrhoa carambolabreast cancerflavonoidsMDA-MB-231 cellspolyphenolstraditional medicinetriple-negative breast cancer
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.